Patient P-01552
Therapy response
Favorable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
19%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S19
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+12
- Toxicity-11
- Inflammatory activity+6
- Nutritional resilience-5
- Treatment adherence+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion11.9/100
worsening · +1.2 vs previous 14 d
Toxicity
Blood5.7/100
worsening · +0.7 vs previous 14 d
Sleep quality
Wearable47.8/100
worsening · -2.4 vs previous 14 d
Energy level
Daily log7.3/10
stable · -0.1 vs previous 14 d
Stress level
Daily log3.3/10
worsening · +0.3 vs previous 14 d
Steps
Wearable3,241
stable · -64 vs previous 14 d
Adherence
Companion93.3 %
stable · -1.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 92 from the failing basin, 7 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep histamine lowGI +3.8 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+3.8detractor · 95%
- Dietary fat load+1.4no signal · 28%
- Simple carbohydrates-0.5no signal · 15%
- Insoluble fibre-0.4no signal · 15%
- Spicy / capsaicin+0.4no signal · 15%
- Alcohol0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Autonomic recovery ↑20
- Wearable3,241 steps/day
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.2 · butyrate capacity 55/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 58 ms
- Sleep
- 6.9 h
- Steps
- 3,802
- Resting HR
- 60 bpm
Daily log: GI score 12, nutritional resilience 72, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.